What does CUSIP 253748206 represent in this 13F holders report?

CUSIP 253748206 is the security identifier for DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW used to aggregate holder disclosures.

How many institutions held DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in Q4 2018?

No institutional holders were reported for DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in Q4 2018; review adjacent reporting periods for trend context.

DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

CUSIP: 253748206

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -4,072,011
Total reported value: $0
Number of holders: 0
Value change: -$1,758,000
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 253748206?
CUSIP 253748206 identifies DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2018

Recent filing periods for CUSIP 253748206:

Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017

DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

Q4 2018 13F Holders as of 31 Dec 2018

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW as of Q4 2018.